<p>Values shown are medians (interquartile ranges) except where noted</p><p><sup>a</sup>Subjects with sufficient viral RNA loads in the CSF (>1,000 copies of viral RNA/ml; to ensure adequate sampling) for further SGA analysis at one or more time points within the first two years.</p><p>Background demographic and clinical characteristics of study participants at baseline.</p
a<p>Values represent n (% with characteristic) or median (interquartile range).</p>b<p>Patient had a...
<p>Percentages exclude missing values: Chronic diseases include arterial hypertension, diabetes mell...
Socio-demographic and COVID-19 characteristics of study participants at baseline.</p
<p>* In Delgard et al., 400.000IU/mL was used as cut-off for high and low viral load</p><p>Baseline ...
<p>Variables are expressed as median (interquartile range) or n (%).</p><p>NS, not significant; HBV,...
<p>Baseline demographic and clinical characteristics of the study participants (n = 199).</p
<p>Baseline Characteristics of All Study Participants in 65 Colonies (32 in Influenza Vaccinated Gro...
<p>Clinical and demographic characteristics of the study subjects by the viral load level (n = 636)....
<p>All values are the mean ± SD, median (interquartile range) or the number of subjects (percent of ...
<p>Demographic and clinical characteristics of study participants at baseline, by study arm.</p
<p>Three patient groups, complete response with viral load <50 copies/ml, partial response with vira...
<p>*Baseline includes all medications used on at least 1 day between informed consent and randomizat...
a<p>Values are expressed as median (interquartile range) or number (percentage).</p>b<p>Patients may...
<p>Baseline demographics and clinical characteristics of the study participants.</p
<p>* Values at baseline prior to endotoxin infusion.</p><p>Demographic and clinical characteristics ...
a<p>Values represent n (% with characteristic) or median (interquartile range).</p>b<p>Patient had a...
<p>Percentages exclude missing values: Chronic diseases include arterial hypertension, diabetes mell...
Socio-demographic and COVID-19 characteristics of study participants at baseline.</p
<p>* In Delgard et al., 400.000IU/mL was used as cut-off for high and low viral load</p><p>Baseline ...
<p>Variables are expressed as median (interquartile range) or n (%).</p><p>NS, not significant; HBV,...
<p>Baseline demographic and clinical characteristics of the study participants (n = 199).</p
<p>Baseline Characteristics of All Study Participants in 65 Colonies (32 in Influenza Vaccinated Gro...
<p>Clinical and demographic characteristics of the study subjects by the viral load level (n = 636)....
<p>All values are the mean ± SD, median (interquartile range) or the number of subjects (percent of ...
<p>Demographic and clinical characteristics of study participants at baseline, by study arm.</p
<p>Three patient groups, complete response with viral load <50 copies/ml, partial response with vira...
<p>*Baseline includes all medications used on at least 1 day between informed consent and randomizat...
a<p>Values are expressed as median (interquartile range) or number (percentage).</p>b<p>Patients may...
<p>Baseline demographics and clinical characteristics of the study participants.</p
<p>* Values at baseline prior to endotoxin infusion.</p><p>Demographic and clinical characteristics ...
a<p>Values represent n (% with characteristic) or median (interquartile range).</p>b<p>Patient had a...
<p>Percentages exclude missing values: Chronic diseases include arterial hypertension, diabetes mell...
Socio-demographic and COVID-19 characteristics of study participants at baseline.</p